Vaccine maker Moderna has forked over $400 million to the National Institutes of Health for using a molecular stabilizing technique borrowed from government and academic researchers in its mRNA-based COVID-19 vaccine-which the company made roughly $36 billion selling amid the deadly pandemic, according to The New York Times.
#people #back #years #development #researchers #vaccination #spokesperson #infectious-diseases #federal-agency #spike-protein
[
add
]
[
|
|
...
]